A survey of 400 cancer patients and caregivers finds that although 75 percent know about generative AI tools, only 24...

A retrospective study of 103 patients with HER2-positive de novo metastatic breast cancer found that those who underwent breast surgery...

The new phase 3 RxFINE-Low trial will test whether patients with low genomic risk but high anatomic risk early-stage breast...

New research from Montreal reveals that the sorting receptor SORT1 links lipid remodeling, stemness and drug resistance in 3D glioblastoma...

A new systematic review finds that clinically significant fear of cancer recurrence affects between 13 and 33.9 percent of survivors...

Brazilian researchers have found that a BCL-2 promoter variant influences protein expression in bladder tumors while a specific haplotype triples...

A national study of more than 316,000 patients finds that while partial breast irradiation has doubled in use, combining it...

The distinction between breast-level and participant-level output deserves careful attention when interpreting the reported performance figures. In clinical breast imaging,...

A Norwegian population-based study finds that the manual mitotic count retains independent prognostic value in hormone receptor-positive, HER2-negative breast cancer...

A machine learning model applied to routine CT urography scans can non-invasively predict HER2 status in bladder cancer, potentially guiding...